Literature DB >> 10467517

Characterization of ATP-sensitive potassium channels in human corporal smooth muscle cells.

S W Lee1, H Z Wang, G J Christ.   

Abstract

Potassium (K) channels play a significant role in modulating human corporal smooth muscle tone, and thus, erectile capacity. Recent pharmacological studies indicate that the metabolically-regulated K channel (KATP) may be an important modulator of human penile erection with significant therapeutic potential. The goal of these initial studies, therefore, was to utilize patch clamp techniques to characterize the putative KATP subtype(s) present in cultured and freshly isolated human corporal smooth muscle cells. In the cell-attached patch mode, two distinct unitary K+ currents were identified whose respective conductance values were similar in cultured and freshly isolated smooth muscle cells. In cultured myocytes, the measured conductance values in symmetric KCl (140 mM) solutions were 59.1 +/- 2.7 pS and 18.4 +/- 2.1 pS (n = 5 cells). Under identical experimental conditions in freshly isolated myocytes, corresponding conductance values were 59.2 +/- 3.7 pS and 18.5 +/- 2.4 pS, respectively (n = 4 cells). I-V curves constructed during step depolarization (-60 to +80 mV), revealed a linear I-V relationship for both unitary conductances. Single channel records documented that both conductances were reversibly inhibited by the application of ATP (1-3 mM) to the bath solution in the inside-out attached patch configuration. The unitary activity of both K channel subtypes was significantly increased by the application of pinacidil (10 microM) and levcromakalim (10 microM). Whole cell patch recordings documented a glibenclamide-sensitive, pinacidil- and levcromakalim-induced increase in the whole cell outward K+ current during step depolarization (-70 mV to +130 mV) of 105 +/- 37%, 139 +/- 42%, respectively. These data confirm and extend our previous observations, and provide the first evidence for the presence of KATP channel subtypes in human corporal smooth muscle cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10467517     DOI: 10.1038/sj.ijir.3900398

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  7 in total

1.  KMUP-1 relaxes rabbit corpus cavernosum smooth muscle in vitro and in vivo: involvement of cyclic GMP and K(+) channels.

Authors:  Rong-Jyh Lin; Bin-Nan Wu; Yi-Ching Lo; Kuo-Pyng Shen; Young-Tso Lin; Chun-Hsiung Huang; Ing-Jun Chen
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

Review 2.  In vitro models: research in physiology and pharmacology of the lower urinary tract.

Authors:  Robert B Moreland
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

3.  Silencing MaxiK activity in corporal smooth muscle cells initiates compensatory mechanisms to maintain calcium homeostasis.

Authors:  Giulia Calenda; Sylvia Ottilie Suadicani; Rodolfo Iglesias; David Conover Spray; Arnold Melman; Kelvin Paul Davies
Journal:  J Sex Med       Date:  2011-01-26       Impact factor: 3.802

4.  Effects of ethanol on the tonicity of corporal tissue and the intracellular Ca2+ concentration of human corporal smooth muscle cells.

Authors:  Sung Chul Kam; Mee Ree Chae; Ji Young Kim; Seol Ho Choo; Deok Hyun Han; Sung Won Lee
Journal:  Asian J Androl       Date:  2010-09-20       Impact factor: 3.285

5.  Neuronal Voltage Gated Potassium Channels May Modulate Nitric Oxide Synthesis in Corpus Cavernosum.

Authors:  Amira M Senbel; Heba M Abd Elmoneim; Fouad M Sharabi; Mahmoud M Mohy El-Din
Journal:  Front Pharmacol       Date:  2017-05-26       Impact factor: 5.810

6.  Exploring scientifically proven herbal aphrodisiacs.

Authors:  Sabna Kotta; Shahid H Ansari; Javed Ali
Journal:  Pharmacogn Rev       Date:  2013-01

Review 7.  Nicorandil: A drug with ongoing benefits and different mechanisms in various diseased conditions.

Authors:  Lamiaa Ahmed Ahmed
Journal:  Indian J Pharmacol       Date:  2019-11-26       Impact factor: 1.200

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.